EUVIMEDEUVIMED entdecken
Crossref

Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity

María Ángeles Núñez-Sánchez, María Antonia Martínez-Sánchez, José Ignacio Martínez-Montoro, Andrés Balaguer-Román, Elena Murcia-García, Virginia Esperanza Fernández-Ruiz, Mercedes Ferrer-Gómez, Carlos Manuel Martínez-Cáceres, Tomasz Sledzinski, María Dolores Frutos, Juan José Hernández-Morante, José Carlos Fernández-García und 4 weitere

The Journal of Clinical Endocrinology & Metabolism · 17.06.2024 · 109 (7) · 1781-1792

DOI: 10.1210/clinem/dgae028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 13.01.2024. Verfasst von María Ángeles Núñez-Sánchez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain. Hauptthemen laut MEDLINE: Liver, Obesity, Lipidomics, Fatty Acids. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Fondo Europeo de Desarrollo Regional, intensification research program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Metabolic dysfunction–associated steatotic liver disease (MASLD) is characterized by the intracellular lipid accumulation in hepatocytes. Excess caloric intake and high-fat diets are considered to significantly contribute to MASLD development.

Objective

To evaluate the hepatic and serum fatty acid (FA) composition in patients with different stages of MASLD, and their relationship with FA dietary intake and MASLD-related risk factors.

Methods

This was a case–control study in patients with obesity undergoing bariatric surgery at a university hospital between January 2020 and December 2021. Participants were distributed in 3 groups: no MASLD (n = 26), steatotic liver disease (n = 33), and metabolic dysfunction–associated steatohepatitis (n = 32). Hepatic and serum FA levels were determined by gas chromatography-mass spectrometry. Nutritional status was evaluated using validated food frequency questionnaires. The hepatic expression of genes involved in FA metabolism was analyzed by reverse transcription quantitative polymerase chain reaction.

Results

The hepatic, but not serum, FA profiles were significantly altered in patients with MASLD compared with those without MASLD. No differences were observed in FA intake between the groups. Levels of C16:0, C18:1, and the C18:1/C18:0 ratio were higher, while C18:0 levels and C18:0/C16:0 ratio were lower in patients with MASLD, being significantly different between the 3 groups. Hepatic FA levels and ratios correlated with histopathological diagnosis and other MASLD-related parameters. The expression of genes involved in the FA metabolism was upregulated in patients with MASLD.

Conclusion

Alterations in hepatic FA levels in MASLD patients were due to enhancement of de novo lipogenesis in the liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverObesityLipidomicsFatty AcidsFatty LiverHumansMaleFemaleCase-Control StudiesAdultMiddle AgedLipid MetabolismBariatric Surgery

Stichwörter der Autor:innen

fatty acidslipidomicslivermetabolic dysfunction-associated steatotic liver diseaseobesitysteatohepatitis

Substanzen

Fatty Acids

Autor:innen und Institutionen

  • Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.
  • Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Biomedical Research Institute of Malaga (IBIMA), Faculty of Medicine, University of Malaga, 29010 Malaga, Spain.
  • Department of General and Digestive System Surgery, Virgen de la Arrixaca University Hospital, 30120 Murcia, Spain.
  • Eating Disorders Research Unit, Faculty of Nursing, UCAM Catholic University of Murcia, 30107 Murcia, Spain.
  • Department of Endocrinology and Nutrition, Virgen de la Arrixaca University Hospital, 30120 Murcia, Spain.
  • Experimental Pathology Service, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain.

ORCID-Profile: Adriana Mika, Bruno Ramos-Molina

Förderung

  • Instituto de Salud Carlos III
  • Fondo Europeo de Desarrollo Regional
  • intensification research program
  • PFIS predoctoral fellowship
  • Stop Fuga de Cerebros
  • Roche
  • Miguel Servet Type I

Zitieren

APA

Núñez-Sánchez, M. Á., Martínez-Sánchez, M. A., Martínez-Montoro, J. I., Balaguer-Román, A., Murcia-García, E., Fernández-Ruiz, V. E., Ferrer-Gómez, M., Martínez-Cáceres, C. M., Sledzinski, T., Frutos, M. D., Hernández-Morante, J. J., Fernández-García, J. C., Queipo-Ortuño, M. I., Ruiz-Alcaraz, A. J., Mika, A., & Ramos-Molina, B. (2024). Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity. The Journal of Clinical Endocrinology & Metabolism, 109(7), 1781-1792. https://doi.org/10.1210/clinem/dgae028

Vancouver

Núñez-Sánchez MÁ, Martínez-Sánchez MA, Martínez-Montoro JI, Balaguer-Román A, Murcia-García E, Fernández-Ruiz VE, et al. Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity. The Journal of Clinical Endocrinology & Metabolism. 2024;109(7):1781-1792. doi:10.1210/clinem/dgae028

BibTeX
@article{NezSnchez2024,
  author = {Núñez-Sánchez, María Ángeles and Martínez-Sánchez, María Antonia and Martínez-Montoro, José Ignacio and Balaguer-Román, Andrés and Murcia-García, Elena and Fernández-Ruiz, Virginia Esperanza and Ferrer-Gómez, Mercedes and Martínez-Cáceres, Carlos Manuel and Sledzinski, Tomasz and Frutos, María Dolores and Hernández-Morante, Juan José and Fernández-García, José Carlos and Queipo-Ortuño, María Isabel and Ruiz-Alcaraz, Antonio José and Mika, Adriana and Ramos-Molina, Bruno},
  title = {Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {7},
  pages = {1781--1792},
  doi = {10.1210/clinem/dgae028}
}
Kostenlos starten →